Isis Biopolymer
Providence
About Isis Biopolymer
Isis Biopolymer, Inc., a medical device company, develops transdermal drug delivery systems for physicians and pharmacists. Its products include the IsisIQ, a compact, wireless, and active iontophoretic patch that delivers various drugs; Gentle Touch, a lidocaine patch for children and elderly; the Pro Patch and Pro Patch+, which administer anesthetic within surgical settings; Bio Youth patch, a transdermal delivery system for skin care treatment around the eye and nasolabial areas; and Biobliss Patch, which provides an alternative to the pain and recovery of injectable remedies. The company was founded in 2006 and is based in Providence, Rhode Island.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $7.0M
- Last round: Series Unknown (Mar 2010)
- Website: isisbiopolymer.com
- Phone: +1 401-921-6868
Industries & Categories
Biotechnology, Medical Device, Pharmaceutical
Canonical: https://fsome.com/organization/isis-biopolymer-1761089 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.